Skip to main content
. 2011 Oct 12;53(11):1092–1099. doi: 10.1093/cid/cir671

Table 2.

Bivariate Analysis of Characteristics Associated With Serological Cure and Serofast Status at 6 Months

Characteristic Serological cure, no. (%) of participants (n = 369) Serofast status, no. (%) of participants (n = 96) OR (95% CI)
Sex
    Male 234 (81.5) 53 (18.5) 1.41 (.89–2.22)
    Female 135 (75.8) 43 (24.1) 1
Age, years
    ≤24 198 (86.8) 30 (13.2) 3.30 (1.67–6.54)
    25–29 84 (83.2) 17 (16.8) 2.47 (1.15–5.33)
    30–39 51 (62.2) 31 (37.8) 0.82 (.40–1.69)
    ≥40 36 (66.7) 18 (33.3) 1
Race/ethnicity
    Black 54 (83.1) 11 (16.9) 1
    White or other 11 (78.6) 3 (21.4) 0.75 (.18–3.13)
    Malagasy 304 (78.8) 82 (21.2) 0.76 (.38–1.51)
Sexual orientation
    Homosexuala 12 (85.7) 2 (14.3) 1
    Heterosexual 353 (79.3) 92 (20.7) 0.64 (.14–2.91)
    Bisexual 3 (60.0) 2 (40.0) 0.25 (.02–2.58)
No. of sex partners in past 6 months
    0–1 135 (84.4) 25 (15.6) 1
    2–5 182 (81.6) 41 (18.4) 0.82 (.48–1.42)
    6–10 32 (69.6) 14 (30.4) 0.43 (.20–.90)
    >10 20 (55.6) 16 (44.4) 0.23 (.11–.51)
History of syphilis
    No 50 (65.8) 26 (34.2) 1
    Yes 21 (63.6) 12 (36.4) 0.91 (.39–2.14)
    Unknown/test not performed 298 (83.7) 58 (16.3) 2.67 (1.54–4.64)
Other medical conditionsb
    No 207 (80.5) 50 (19.5) 1
    Yes 162 (77.9) 46 (22.1) 0.85 (.54–1.33)
Syphilis stage
    Primary 100 (87.0) 15 (13.0) 1
    Secondary 187 (85.8) 31 (14.2) 0.91 (.47–1.76)
    Early latent 82 (62.1) 50 (37.9) 0.25 (.13–.47)
Baseline RPR titer
    ≤1:32 126 (62.7) 75 (37.3) 1
    >1:32 243(92.1) 21 (8.0) 6.89 (4.06–11.70)
Treatment regimen
    Benzathine penicillin 182 (79.1) 48 (20.9) 1
    Azithromycin 187 (79.6) 48 (20.4) 1.03 (.66–1.61)
Jarisch-Herxheimer reaction
    No 223 (77.2) 66 (22.8) 1
    Yes 146 (83.9) 28 (16.1) 1.54 (.95–2.52)

Abbreviations: CI, confidence interval; OR, odds ratio; RPR, rapid plasma reagin.

a

Homosexual participants included 12 men who had sex with men and 2 women.

b

Other medical conditions included any other significantly relevant medical problems reported by participants that involved ≥1 organ systems.